Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, JmjC domain-containing histone demethylation protein 3A | 8 | 0 | 0 | 8 |
acetylcholinesterase | 17 | 0 | 0 | 17 |
pregnane X receptor | 6 | 0 | 0 | 6 |
RAR-related orphan receptor gamma | 25 | 0 | 0 | 25 |
TDP1 protein | 20 | 0 | 0 | 20 |
GLI family zinc finger 3 | 30 | 0 | 0 | 30 |
AR protein | 40 | 0 | 0 | 40 |
aldehyde dehydrogenase 1 family, member A1 | 21 | 0 | 0 | 21 |
thyroid stimulating hormone receptor | 18 | 0 | 0 | 18 |
estrogen receptor 2 (ER beta) | 18 | 0 | 0 | 18 |
nuclear receptor subfamily 1, group I, member 3 | 30 | 0 | 0 | 30 |
glucocorticoid receptor [Homo sapiens] | 31 | 0 | 0 | 31 |
retinoic acid nuclear receptor alpha variant 1 | 30 | 0 | 0 | 30 |
retinoid X nuclear receptor alpha | 27 | 0 | 0 | 27 |
estrogen-related nuclear receptor alpha | 31 | 0 | 0 | 31 |
estrogen nuclear receptor alpha | 39 | 0 | 0 | 39 |
67.9K protein | 8 | 0 | 0 | 8 |
peroxisome proliferator-activated receptor delta | 20 | 0 | 0 | 20 |
peroxisome proliferator activated receptor gamma | 20 | 0 | 0 | 20 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 25 | 0 | 0 | 25 |
aryl hydrocarbon receptor | 16 | 0 | 0 | 16 |
cellular tumor antigen p53 isoform a | 8 | 0 | 0 | 8 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 8 | 0 | 0 | 8 |
thyroid hormone receptor beta isoform a | 8 | 0 | 0 | 8 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 9 | 0 | 0 | 9 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 26 | 0 | 0 | 26 |
histone deacetylase 9 isoform 3 | 5 | 0 | 0 | 5 |
mitogen-activated protein kinase 1 | 8 | 0 | 0 | 8 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 31 | 0 | 0 | 31 |
nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
geminin | 24 | 0 | 0 | 24 |
survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
histone acetyltransferase KAT2A isoform 1 | 11 | 0 | 0 | 11 |
Voltage-dependent calcium channel gamma-2 subunit | 18 | 0 | 0 | 18 |
Cellular tumor antigen p53 | 26 | 0 | 0 | 26 |
Integrin beta-3 | 8 | 0 | 0 | 8 |
Integrin alpha-IIb | 8 | 0 | 0 | 8 |
Glutamate receptor 2 | 18 | 0 | 0 | 18 |
Nuclear receptor ROR-gamma | 10 | 0 | 0 | 10 |
TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
Ataxin-2 | 14 | 0 | 0 | 14 |
Luciferase | 13 | 0 | 0 | 13 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
SMAD family member 2 | 10 | 0 | 0 | 10 |
SMAD family member 3 | 10 | 0 | 0 | 10 |
progesterone receptor | 24 | 0 | 0 | 24 |
farnesoid X nuclear receptor | 20 | 0 | 0 | 20 |
pregnane X nuclear receptor | 31 | 0 | 0 | 31 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 19 | 0 | 0 | 19 |
activating transcription factor 6 | 17 | 0 | 0 | 17 |
thyrotropin-releasing hormone receptor | 5 | 0 | 0 | 5 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 13 | 0 | 0 | 13 |
heat shock protein beta-1 | 11 | 0 | 0 | 11 |
Sporulation initiation phosphotransferase F | 0 | 1 | 0 | 1 |
Sporulation kinase A | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
Thromboxane-A synthase | 0 | 3 | 0 | 3 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 6 | 1 | 8 |
Mitogen-activated protein kinase 14 | 0 | 4 | 0 | 4 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 18 | 0 | 0 | 18 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Microtubule-associated protein tau | 13 | 0 | 0 | 13 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 19 | 0 | 0 | 19 |
G | 13 | 0 | 0 | 13 |
cytochrome P450 2D6 | 17 | 0 | 0 | 17 |
euchromatic histone-lysine N-methyltransferase 2 | 34 | 0 | 0 | 34 |
thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
Histone H2A.x | 16 | 0 | 0 | 16 |
vitamin D3 receptor isoform VDRA | 14 | 0 | 0 | 14 |
DNA polymerase kappa isoform 1 | 9 | 0 | 0 | 9 |
peripheral myelin protein 22 | 20 | 0 | 0 | 20 |
Interferon beta | 15 | 0 | 0 | 15 |
HLA class I histocompatibility antigen, B alpha chain | 13 | 0 | 0 | 13 |
Inositol hexakisphosphate kinase 1 | 13 | 0 | 0 | 13 |
cytochrome P450 2C9, partial | 13 | 0 | 0 | 13 |
Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 18 | 0 | 0 | 18 |
HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
Heat shock protein HSP 90-beta | 0 | 1 | 1 | 3 |
2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
Endoplasmin | 0 | 0 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 16 | 5 | 23 |
Delta-type opioid receptor | 0 | 7 | 4 | 13 |
Kappa-type opioid receptor | 0 | 11 | 5 | 18 |
Endoplasmin | 0 | 1 | 1 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 1 | 2 |
Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
glp-1 receptor, partial | 10 | 0 | 0 | 10 |
thioredoxin reductase | 21 | 0 | 0 | 21 |
GLS protein | 18 | 0 | 0 | 18 |
NPYLR7B | 0 | 0 | 1 | 1 |
arylsulfatase A | 17 | 0 | 0 | 17 |
flap endonuclease 1 | 9 | 0 | 0 | 9 |
ATP-binding cassette sub-family C member 3 | 0 | 23 | 0 | 23 |
Multidrug resistance-associated protein 4 | 0 | 23 | 0 | 25 |
Bile salt export pump | 0 | 33 | 0 | 33 |
Beta-2 adrenergic receptor | 0 | 2 | 2 | 4 |
Beta-1 adrenergic receptor | 0 | 2 | 2 | 4 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 4 | 1 | 5 |
Delta-type opioid receptor | 0 | 8 | 4 | 13 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 3 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 3 | 2 | 5 |
Canalicular multispecific organic anion transporter 1 | 0 | 22 | 0 | 22 |
ATP-dependent phosphofructokinase | 19 | 0 | 0 | 19 |
Chain A, 2-oxoglutarate Oxygenase | 12 | 0 | 0 | 12 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
Smad3 | 4 | 0 | 0 | 4 |
microphthalmia-associated transcription factor isoform 9 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 11 | 0 | 13 |
Carbonic anhydrase 2 | 0 | 11 | 1 | 14 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 1 | 4 |
Chain A, HADH2 protein | 11 | 0 | 0 | 11 |
Chain B, HADH2 protein | 11 | 0 | 0 | 11 |
Chain A, Cruzipain | 8 | 0 | 0 | 8 |
interleukin 8 | 7 | 0 | 0 | 7 |
phosphopantetheinyl transferase | 13 | 0 | 0 | 13 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 23 | 0 | 0 | 23 |
Cytochrome P450 1A2 | 0 | 4 | 0 | 6 |
Cytochrome P450 3A4 | 0 | 9 | 2 | 15 |
Cytochrome P450 2D6 | 0 | 7 | 0 | 7 |
Cytochrome P450 2C9 | 0 | 9 | 0 | 10 |
Cytochrome P450 2C19 | 0 | 3 | 0 | 4 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 13 | 0 | 13 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 1 | 6 |
Apelin receptor | 0 | 1 | 1 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
NFKB1 protein, partial | 7 | 0 | 0 | 7 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 7 | 0 | 0 | 7 |
chromobox protein homolog 1 | 24 | 0 | 0 | 24 |
DNA polymerase iota isoform a (long) | 10 | 0 | 0 | 10 |
muscarinic acetylcholine receptor M1 | 11 | 0 | 0 | 11 |
lethal factor (plasmid) | 11 | 0 | 0 | 11 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 3 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 1 | 4 |
Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 1 | 3 | 5 |
Vasopressin V2 receptor | 0 | 3 | 2 | 6 |
Oxytocin receptor | 0 | 3 | 3 | 6 |
Vasopressin V1a receptor | 0 | 1 | 2 | 3 |
Vasopressin V1a receptor | 0 | 3 | 2 | 5 |
Vasopressin V1b receptor | 0 | 2 | 2 | 4 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 2 | 1 | 4 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 2 | 1 | 3 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
IDH1 | 5 | 0 | 0 | 5 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 3 | 0 | 0 | 3 |
Polyphenol oxidase 2 | 0 | 3 | 0 | 4 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 17 | 3 | 21 |
Spike glycoprotein | 13 | 0 | 1 | 14 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Amino acid transporter | 0 | 2 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 10 | 0 | 0 | 10 |
Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
Glutamate transporter homolog | 0 | 0 | 1 | 1 |
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 1 | 6 |
Excitatory amino acid transporter 1 | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 2 | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 1 | 6 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 1 | 6 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 1 | 6 |
Metabotropic glutamate receptor 1 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 1 | 6 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 1 | 6 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 1 | 6 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 4 | 0 | 0 | 4 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 8 | 0 | 10 |
5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
Muscarinic acetylcholine receptor M2 | 0 | 8 | 4 | 15 |
Muscarinic acetylcholine receptor M4 | 0 | 7 | 3 | 12 |
Muscarinic acetylcholine receptor M1 | 0 | 10 | 1 | 14 |
Muscarinic acetylcholine receptor M3 | 0 | 10 | 1 | 14 |
Muscarinic acetylcholine receptor M4 | 0 | 10 | 1 | 14 |
Muscarinic acetylcholine receptor M5 | 0 | 11 | 1 | 15 |
Muscarinic acetylcholine receptor M5 | 0 | 8 | 3 | 13 |
Muscarinic acetylcholine receptor M2 | 0 | 10 | 1 | 15 |
Muscarinic acetylcholine receptor M1 | 0 | 9 | 5 | 17 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 2 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 6 | 3 | 11 |
Alpha-1D adrenergic receptor | 0 | 12 | 2 | 14 |
5-hydroxytryptamine receptor 2C | 0 | 11 | 0 | 11 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 10 | 2 | 0 | 15 |
5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 3 | 1 | 4 |
ATAD5 protein, partial | 14 | 0 | 0 | 14 |
D(1A) dopamine receptor | 10 | 0 | 0 | 10 |
cytochrome P450 3A4 isoform 1 | 19 | 0 | 0 | 19 |
Gamma-aminobutyric acid receptor subunit pi | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit delta | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 19 | 5 | 2 | 26 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 19 | 6 | 2 | 27 |
Gamma-aminobutyric acid receptor subunit beta-3 | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit beta-2 | 19 | 5 | 2 | 26 |
GABA theta subunit | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid receptor subunit epsilon | 19 | 5 | 1 | 25 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 3 | 0 | 0 | 3 |
apical membrane antigen 1, AMA1 | 6 | 0 | 0 | 6 |
caspase 7, apoptosis-related cysteine protease | 8 | 0 | 0 | 8 |
caspase-3 | 8 | 0 | 0 | 8 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 11 | 0 | 0 | 11 |
importin subunit beta-1 isoform 1 | 7 | 0 | 0 | 7 |
snurportin-1 | 7 | 0 | 0 | 7 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 8 | 0 | 0 | 8 |
GTP-binding nuclear protein Ran isoform 1 | 5 | 0 | 0 | 5 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase Fyn | 0 | 4 | 0 | 4 |
Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 4 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 13 | 1 | 14 |
Histamine H3 receptor | 0 | 3 | 0 | 3 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
USP1 protein, partial | 15 | 0 | 0 | 15 |
PPM1D protein | 3 | 0 | 0 | 3 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Androgen receptor | 1 | 5 | 3 | 11 |
Vitamin D3 receptor | 0 | 2 | 3 | 8 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
Kappa-type opioid receptor | 0 | 6 | 2 | 8 |
Vitamin D3 receptor | 0 | 0 | 2 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 2 | 0 | 2 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Caspase-7 | 4 | 0 | 0 | 4 |
interferon gamma precursor | 0 | 0 | 0 | 2 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 15 | 0 | 0 | 15 |
caspase-3 | 4 | 0 | 0 | 4 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 1 | 1 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 10 | 0 | 10 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 3 | 0 | 5 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
Quinolone resistance protein NorA | 0 | 2 | 0 | 3 |
Adenosine receptor A3 | 0 | 6 | 0 | 6 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 3 | 0 | 5 |
Alpha-1B adrenergic receptor | 0 | 16 | 3 | 19 |
Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 12 | 1 | 13 |
D(1A) dopamine receptor | 0 | 7 | 1 | 9 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 14 | 1 | 15 |
Adenosine receptor A1 | 0 | 2 | 1 | 3 |
Cruzipain | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 16 | 0 | 16 |
Sodium-dependent serotonin transporter | 0 | 6 | 1 | 7 |
Delta-type opioid receptor | 0 | 7 | 2 | 12 |
Mu-type opioid receptor | 0 | 9 | 4 | 16 |
Bifunctional epoxide hydrolase 2 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 17 | 4 | 21 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
D(2) dopamine receptor | 0 | 8 | 3 | 12 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 9 | 2 | 11 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 7 | 0 | 7 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 4 | 0 | 4 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 3 | 0 | 3 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 4 | 0 | 4 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 6 | 3 | 9 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 6 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 6 | 2 | 8 |
Translocator protein | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 2 | 0 | 2 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 6 | 3 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 6 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 6 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 6 | 0 | 6 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 12 | 0 | 0 | 12 |
cytochrome P450 2C9 precursor | 6 | 0 | 0 | 6 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 13 | 3 | 17 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2C adrenergic receptor | 0 | 14 | 3 | 18 |
D | 0 | 6 | 0 | 7 |
D(3) dopamine receptor | 0 | 5 | 0 | 5 |
Alpha-2B adrenergic receptor | 0 | 8 | 3 | 11 |
Alpha-2C adrenergic receptor | 0 | 8 | 3 | 11 |
Alpha-2A adrenergic receptor | 0 | 8 | 3 | 11 |
Alpha-1D adrenergic receptor | 0 | 9 | 3 | 13 |
D(1B) dopamine receptor | 0 | 4 | 0 | 4 |
Amine oxidase [flavin-containing] B | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 1B | 0 | 7 | 0 | 7 |
Adenosine receptor A2b | 0 | 0 | 1 | 1 |
Adenosine receptor A2a | 0 | 0 | 3 | 3 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
D(4) dopamine receptor | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 5 | 2 | 7 |
Alpha-1B adrenergic receptor | 0 | 4 | 2 | 6 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Nischarin | 0 | 3 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 2 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Efflux transporter | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
dopamine D1 receptor | 4 | 0 | 0 | 4 |
hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
glucokinase regulatory protein | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 8 | 0 | 0 | 8 |
Thrombopoietin | 3 | 0 | 0 | 3 |
huntingtin isoform 2 | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
serine/threonine-protein kinase mTOR isoform 1 | 7 | 0 | 0 | 7 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 5 | 0 | 0 | 5 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 2 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 7 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 12 | 0 | 12 |
5-hydroxytryptamine receptor 1D | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1F | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 5B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 3 | 0 | 3 |
D(1A) dopamine receptor | 6 | 1 | 0 | 7 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Transporter | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 0 | 2 | 2 |
ATP-dependent translocase ABCB1 | 0 | 7 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
transcriptional regulator ERG isoform 3 | 4 | 0 | 0 | 4 |
Plasma kallikrein | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 1 | 7 | 2 | 13 |
Sex hormone-binding globulin | 0 | 1 | 3 | 4 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 5 | 2 | 9 |
Glucocorticoid receptor | 0 | 2 | 1 | 4 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 1 | 3 | 1 | 6 |
Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
Aromatase | 0 | 3 | 0 | 4 |
Androgen receptor | 0 | 15 | 1 | 16 |
Androgen receptor | 0 | 1 | 1 | 2 |
Mineralocorticoid receptor | 0 | 1 | 1 | 2 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Fumarate hydratase | 5 | 0 | 0 | 5 |
GALC protein | 3 | 0 | 0 | 3 |
polyprotein | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
D(2) dopamine receptor | 0 | 9 | 1 | 12 |
Histamine H1 receptor | 0 | 7 | 0 | 7 |
D(3) dopamine receptor | 0 | 6 | 1 | 9 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 3 | 0 | 4 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 2 | 0 | 2 |
Opioid receptor homologue | 0 | 2 | 0 | 2 |
Proenkephalin-B | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 4 | 1 | 7 |
Kappa-type opioid receptor | 0 | 6 | 3 | 10 |
Mu-type opioid receptor | 0 | 4 | 1 | 8 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
Estrogen receptor | 1 | 11 | 5 | 21 |
Estrogen receptor | 0 | 2 | 2 | 5 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
Estrogen receptor beta | 0 | 1 | 2 | 4 |
endonuclease IV | 4 | 0 | 0 | 4 |
nonstructural protein 1 | 4 | 0 | 0 | 4 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
Alpha-synuclein | 2 | 1 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 1 | 8 | 3 | 13 |
Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 0 | 3 |
bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Steroid hormone receptor ERR1 | 0 | 2 | 0 | 2 |
Bile acid receptor | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 2 | 2 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 4 | 1 | 7 |
D(1B) dopamine receptor | 0 | 3 | 0 | 4 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 4 | 0 | 4 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
C-8 sterol isomerase | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 1 | 4 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 9 | 0 | 9 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Nrf2 | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
Snq2p | 0 | 0 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 2 | 0 | 2 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 3 |
Pantothenate synthetase | 0 | 1 | 0 | 1 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Thermolysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
ClpP | 3 | 0 | 0 | 3 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 3 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
High mobility group protein B1 | 0 | 0 | 2 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 2 | 4 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 2 | 3 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
hypothetical protein, conserved | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Tegument protein VP16 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 3 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
MCOLN3 protein | 0 | 0 | 1 | 1 |
transient receptor potential cation channel, subfamily N, member 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 2 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Pyrroline-5-carboxylate reductase 1, mitochondrial | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
G-protein coupled receptor 55 | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
Chromaffin granule amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 2 | 1 | 3 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 2 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 2 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 4 | 0 | 4 |
Substance-P receptor | 0 | 4 | 1 | 5 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Tumor necrosis factor | 0 | 0 | 1 | 1 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
Chain A, CES1 protein | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Protein kinase C iota type | 0 | 1 | 0 | 1 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |